https://doi.org/10.4081/cdr.11.11679
Drug-Induced Interstitial Lung Disease in a patient treated with a combination of palbociclib and fulvestrant
Accepted: 26 October 2023
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
A 59-year-old patient without a history of pulmonary disease presented with episodes of hemoptysis and acute respiratory failure after being treated for metastatic breast cancer with fulvestrant and palbociclib. The high-resolution chest CT revealed diffuse ground glass opacities and diffuse smooth thickening of the interlobular septa and peribronchovascular interstitium, consistent with drug-induced interstitial lung disease (DIILD). A few days of high-dose steroid treatment increased the patient's PaO2/FiO2 from 75 to 200. Following hospital discharge, the oncologist resumed fulvestrant therapy, with no further adverse events occurring during subsequent follow-up.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Arpitha Anantharaju, Pratap Upadhya, Sivaselvi Chellamuthu, Ashwini Raj, Vishnukath Govindaraj, Gowri Dorairajan, A rare cause of respiratory failure in pregnancy - acute exacerbation of undiagnosed hypersensitivity pneumonitis mimicking complication of severe preeclampsia , Chest Disease Reports: Vol. 11 (2023)
- Hasan S. Yamin, Amro Y. Alastal, Izzedin Bakri, Epidemiology of interstitial lung disease in Palestine: first national data , Chest Disease Reports: Vol. 7 (2017)
You may also start an advanced similarity search for this article.
